October 2013

Price for Xpert® MTB/RIF and FIND country list

Enhancement of diagnostic capacity for TB and MDR-TB is urgently needed to scale-up access to care and treatment of MDR-TB. To help meet this challenge, FIND has collaborated in the development and evaluation of new TB diagnostic tools, including cartridge-based automated NAAT technology. WHO has officially endorsed the use of this new tool based on the thorough evaluation of the evidence of its effectiveness under actual programme conditions. As part of its role in the development and evaluation process of this tool, FIND has successfully negotiated with Cepheid, our manufacturing partner, to obtain significant price reductions for the Xpert® MTB/RIF in order to facilitate access to these diagnostic technologies. On August 6th, 2012 PEPFAR, USAID, UNITAID and Bill & Melinda Gates Foundation finalized an agreement with Cepheid to further reduce the negotiated price of the Xpert MTB/RIF test for eligible customers of the FIND country list to US$ 9.98, Ex works and prepaid.

About these prices

Both the GeneXpert instruments and the Xpert MTB/RIF test cartridges are offered to the FIND Markets at very significant discounts when compared to the commercial markets.

Xpert MTB/RIF test price

Effective August 6th, 2012, the public sector in eligible countries can now purchase test cartridges at the cost of US$ 9.98, Ex works and prepaid.

Instrument price

Instrument GeneXpert IV-module with desktop GeneXpert IV-module with laptop
Price (Ex works & prepaid) US$ 17,000 US$ 17,500

Instrument warranty, support and calibration costs

All GeneXpert systems, with the exception of the GeneXpert Infinity product line, come with a 24-month warranty on service and parts, and there is a hotline and e-mail support. Cepheid and FIND have worked on different scenarios for after-sales service, support and preventive maintenance, including module re-calibration required once per annum. For more details, please refer to Cepheid Cares website: http://www.cepheidcares.com/tb/cepheid-warranty.html

Warranties cover instrument or module repair and/or replacement, as well as kits for annual calibration. All shipment costs are included. Not included are travel costs for all onsite interventions.

 

Instrument Current costs 3-year warranty extension 5-year warranty
GeneXpert-IV

Warranty renewed annually at $2,900/year

$8,700
3-year costs

3-year warranty extension

$ 7,900
(paid upfront)

Taken at the time of instrument purchase

$ 6,850
(paid upfront)

GeneXpert-XVI

Warranty renewed annually at $7,800/year

$ 23,400
3-year costs

3-year warranty extension

$ 20,900
(paid upfront)

Taken at the time of instrument purchase

$18,500
(paid upfront)

Instrument calibration service

GeneXpert Module Calibration Today:
Module Exchange
Future :
On-Site Remote Calibration
Availability Now Now
Calibration cost
(4 modules)
US$ 1,400 US$ 450 (see Note below)
Description Module exchange On-site remote calibration (no module replacement required; however, see Note below)
Shipping cost
(4 modules)
US$ 400 None (if the Remote Calibration Kit is shipped with other tests or systems)
Total US$ 1,800 US$ 450

Note: Xpert calibration test results may invoke a required module replacement if certain test conditions are not met. Costs for this service will be quoted on a case by case basis by your assigned Authorized Service Provider (ASP) and will also take into account whether the system is still covered under the factory warranty.

 

Purchase orders

The public sector in eligible countries can purchase instruments and test cartridges by contacting Cepheid directly at the address below and mentioning the negotiated preferential price.

Contact details

Cepheid HBDC
Vira Solelh
81470 Maurens-Scopont, France
Telephone +33 563 825 309
Fax +33 563 825 301
Email: hbdc@cepheidsas.com

 

About eligible countries

FIND has leveraged its investment in the development of Xpert MTB/RIF by negotiating a price reduction agreement with Cepheid. This agreement fixes the pricing and defines the applicable market as the public sector in 145 high-burden and developing countries.

The public sector in eligible countries is defined as: 

  • Governments or government-funded institutions such as Ministry of Health, associated hospitals, armed forces, prison services in those countries;
  • NGOs and UN-related organizations working for or in those countries such as International Organization for Migration (IOM) and UNICEF;
  • Not-for-profit organizations such as Médecins Sans Frontières, Save-the-Children, OXFAM and the International Committee of the Red Cross (ICRC);
  • Funding mechanisms such as GDF, UNITAID, PEPFAR, USAID, Global Fund, etc. and agencies based outside the country but who are supporting implementation locally in the country, such as the USA-CDC and The Union;
     
  • Not-for-profit, private organizations recognized by the local Ministry of Health, whose mission is in line with humanitarian principles such as private charities and/or private not-for-profit hospitals and clinics, on a case-by-case basis.

Eligible country list

Countries for which FIND-negotiated prices are available (April 2011).

Afghanistan
Dominican Republic
Lithuania
Sao Tome & Principe
Albania
Ecuador
Macedonia
Senegal
Algeria
Egypt
Madagascar
Serbia
Angola
El Salvador
Malawi
Seychelles
Antigua & Barbuda
Eritrea
Malaysia
Sierra Leone
Argentina
Estonia
Maldives
Solomon Islands
Armenia
Ethiopia
Mali
Somalia
Azerbaijan
Fiji
Mauritania
South Africa
Bangladesh
Gabon
Mauritius
Sri Lanka
Belarus
Gambia (The)
Mexico
Sudan
Belize
Gaza Strip
Micronesia
Sudan, South
Benin
Georgia
Moldova
Suriname
Bhutan
Ghana
Mongolia
Swaziland
Bolivia
Grenada
Montenegro
Syria
Bosnia-Herzegovina
Guatemala
Morocco
Tajikistan
Botswana
Guinea
Mozambique
Tanzania
Brazil
Guinea-Bissau
Myanmar (Burma)
Thailand
Bulgaria
Guinea, Equatorial
Namibia
Timor-Leste
Burkina Faso
Haiti
Nauru
Togo
Burundi
Honduras
Nepal
Tonga
Cabo Verde
India
Nicaragua
Tunisia
Cambodia
Indonesia
Niger
Turkmenistan
Cameroon
Iraq
Nigeria
Tuvalu
Central African Republic
Jamaica
Pakistan
Uganda
Chad
Jordan
Palau
Ukraine
Chile
Kazakhstan
Panama
Uruguay
China
Kenya
Papua New Guinea
Uzbekistan
Colombia
Kiribati
Paraguay
Vanuatu
Comoros
Korea, North
Peru
Venezuela
Congo (Democratic Rep. of)
Kosovo
Philippines
Vietnam
Congo (Republic of the)
Kyrgyztan
Romania
Western Sahara
Costa Rica
Laos
Russia
Yemen
Côte d'Ivoire
Latvia
Rwanda
Zambia
Croatia
Lebanon
St Kitts and Nevis
Zimbabwe
Cuba
Lesotho
St Lucia
 
Djibouti
Liberia
St Vincent & Grenadines
 
Dominica
Libya
Samoa